Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
- Flow cytometry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN952067 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-ELMO/CED-12 Domain Containing 2 (ELMOD2) (AA 258-287), (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Purified through a Protein A column followed by peptide affinity purification
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- C-Term, AA 258-287
- Vial size
- 0.4 mL
- Handling
- Avoid repeated freezing and thawing.
Submitted references ELMOD2, a candidate gene for idiopathic pulmonary fibrosis, regulates antiviral responses.
ELMOD2 is an Arl2 GTPase-activating protein that also acts on Arfs.
ELMOD2 is a candidate gene for familial idiopathic pulmonary fibrosis.
Pulkkinen V, Bruce S, Rintahaka J, Hodgson U, Laitinen T, Alenius H, Kinnula VL, Myllärniemi M, Matikainen S, Kere J
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2010 Apr;24(4):1167-77
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2010 Apr;24(4):1167-77
ELMOD2 is an Arl2 GTPase-activating protein that also acts on Arfs.
Bowzard JB, Cheng D, Peng J, Kahn RA
The Journal of biological chemistry 2007 Jun 15;282(24):17568-80
The Journal of biological chemistry 2007 Jun 15;282(24):17568-80
ELMOD2 is a candidate gene for familial idiopathic pulmonary fibrosis.
Hodgson U, Pulkkinen V, Dixon M, Peyrard-Janvid M, Rehn M, Lahermo P, Ollikainen V, Salmenkivi K, Kinnula V, Kere J, Tukiainen P, Laitinen T
American journal of human genetics 2006 Jul;79(1):149-54
American journal of human genetics 2006 Jul;79(1):149-54
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- FACS